We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.74%
2 Healthcare 2.42%
3 Financials 2.31%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYD icon
7751
CALL
VanEck High Yield Muni ETF
HYD
$4.4B
$930K ﹤0.01%
16,200
+6,300
+64% +$377K
HAAC
7752
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
$930K ﹤0.01%
94,451
-3,601
-4% -$35.3K
AGIO icon
7753
CALL
Agios Pharmaceuticals
AGIO
$2B
$929K ﹤0.01%
31,900
+14,100
+79% +$431K
GPK icon
7754
PUT
Graphic Packaging
GPK
$3.38B
$928K ﹤0.01%
46,300
+2,100
+5% +$40.8K
KALV
7755
DELISTED
KalVista Pharmaceuticals
KALV
$928K ﹤0.01%
62,970
+45,564
+262% +$655K
KOD icon
7756
PUT
Kodiak Sciences
KOD
$2.6B
$928K ﹤0.01%
120,200
+82,700
+221% +$3.23M
PACB icon
7757
CALL
Pacific Biosciences
PACB
$357M
$928K ﹤0.01%
102,000
+14,800
+17% +$170K
WHWK
7758
CALL
Whitehawk Therapeutics
WHWK
$254M
$928K ﹤0.01%
+54,700
New +$1.05M
BCS icon
7759
CALL
Barclays
BCS
$94.7B
$927K ﹤0.01%
117,300
-172,900
-60% -$1.76M
HUYA
7760
Huya Inc
HUYA
$529M
$927K ﹤0.01%
207,499
-132,874
-39% -$763K
VIVO
7761
CALL
DELISTED
Meridian Bioscience Inc
VIVO
$927K ﹤0.01%
35,700
-23,000
-39% -$547K
FRO icon
7762
CALL
Frontline
FRO
$9.17B
$926K ﹤0.01%
105,200
+700
+0.7% +$5.54K
GBIL icon
7763
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.59B
$926K ﹤0.01%
9,262
+2,115
+30% +$211K
RBUS
7764
DELISTED
Nationwide Risk-Based U.S. Equity ETF
RBUS
$926K ﹤0.01%
+23,430
New +$909K
AGIO icon
7765
Agios Pharmaceuticals
AGIO
$2B
$925K ﹤0.01%
31,763
+11,534
+57% +$352K
DBO icon
7766
CALL
Invesco DB Oil Fund
DBO
$391M
$925K ﹤0.01%
+53,400
New +$847K
OMER icon
7767
CALL
Omeros
OMER
$1.24B
$925K ﹤0.01%
153,900
+20,800
+16% +$130K
RC
7768
PUT
Ready Capital
RC
$306M
$925K ﹤0.01%
61,400
+6,700
+12% +$100K
TPLC icon
7769
Timothy Plan US Large/Mid Cap Core ETF
TPLC
$319M
$925K ﹤0.01%
25,426
-4,819
-16% -$172K
EVR icon
7770
CALL
Evercore
EVR
$11.8B
$924K ﹤0.01%
8,300
-2,900
-26% -$357K
THR
7771
DELISTED
Thermon Group Holdings
THR
$924K ﹤0.01%
57,024
-326
-0.6% -$5.67K
ABX
7772
Abacus Global Management
ABX
$907M
$923K ﹤0.01%
93,045
-77
-0.1% -$761
SNDX icon
7773
CALL
Syndax Pharmaceuticals
SNDX
$1.77B
$923K ﹤0.01%
53,100
+41,600
+362% +$700K
EDC icon
7774
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$167M
$922K ﹤0.01%
16,795
+12,796
+320% +$839K
SITE icon
7775
CALL
SiteOne Landscape Supply
SITE
$4.3B
$922K ﹤0.01%
5,700
+2,800
+97% +$509K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.